CSCI
COSCIENS Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.72
+0.00%Latest reported
- Last report date
- Aug 14, 2025
- EPS actual
- -$0.85
- EPS estimate
- —
- Revenue actual
- $2.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -24.0%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2025 | — | -$0.85 | — | $2.0M |
| Apr 9, 2025 | -$3.48 | -$2.15 | Beat 38.22% | $1.5M |
| Mar 28, 2025 | — | -$4.64 | — | $3.3M |
| Aug 13, 2024 | -$3.28 | -$0.64 | Beat 80.49% | $2.3M |
| Nov 9, 2023 | -$2.44 | -$3.40 | Miss -39.34% | — |
| Mar 23, 2023 | -$3.72 | -$10 | Miss -175.27% | $2.5M |
| Nov 3, 2022 | -$2.72 | -$2.80 | Miss -2.94% | $1.9M |
| Aug 3, 2022 | -$2.72 | -$3.48 | Miss -27.94% | -$222.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2026